Table 2.
Clinical features | Median levels of serum hs CRP in mg/l (IQR) | p value |
---|---|---|
Fever | ||
Positive group (n = 52) | 25 (24.30–25.00) | 1.000 |
Negative group (n = 8) | 25 (13.69–25.00) | |
Evening rise of temperature | ||
Positive group (n = 13) | 25 (22.69–25.00) | 0.184 |
Negative group (n = 47) | 25 (24.58–25.00) | |
Chills | ||
Positive group (n = 8) | 24.02 (21.27–25.00) | 0.047 |
Negative group (n = 52) | 25 (24.68–25.00) | |
Cough | ||
Positive group (n = 34) | 25 (24.81–25.00) | 0.316 |
Negative group (n = 26) | 25 (24.24–25.00) | |
Dyspnea | ||
Positive group (n = 15) | 25 (22.06–25.00) | 0.705 |
Negative group (n = 45) | 25 (24.35–25.00) | |
H/o recurrent pneumonia | ||
Positive group (n = 4) | 25 (22.79–25.00) | 0.830 |
Negative group (n = 56) | 25 (24.30–25.00) | |
Loss of appetite | ||
Positive group (n = 49) | 25 (23.90–25.00) | 0.525 |
Negative group (n = 11) | 25 (24.58–25.00) | |
Weight loss | ||
Positive group (n = 46) | 25 (24.06–25.00) | 0.371 |
Negative group (n = 14) | 25 (24.87–25.00) | |
Abdominal pain | ||
Positive group (n = 7) | 25 (22.06–25.00) | 0.668 |
Negative group (n = 53) | 25 (24.35–25.00) | |
Lymphadenopathy | ||
Positive group (n = 10) | 24.35 (17.50–25.00) | 0.020 |
Negative group (n = 50) | 25 (24.90–25.00) | |
Vomiting | ||
Positive group (n = 18) | 25 (24.24–25.00) | 0.662 |
Negative group (n = 42) | 25 (24.41–25.00) | |
Headache | ||
Positive group (n = 8) | 25 (18.07–25.00) | 0.564 |
Negative group (n = 52) | 25 (24.30–25.00) | |
Seizure | ||
Positive group (n = 15) | 25 (24.24–25.00) | 0.899 |
Negative group (n = 45) | 25 (24.35–25.00) |
Bold values indicates statistically significant values